Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (571-580 of 633) with videos related to

Pageof 64
Sort By:
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
Journal of Hepatology|January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology|April 16, 2023
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis BFlorian van Bömmel, Kerstin Stein, Renate Heyne, et al.
Zeitschrift Fur Gastroenterologie|November 10, 2025
[Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults]Jonel Trebicka, Christian Steib, Alexander Zipprich, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasiansFelix Stickel, Stephan Buch, Katharina Lau, et al.
Pageof 64

Showing results (571-580 of 633) with videos related to

Sort By:
Pageof 64
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
Journal of Hepatology|January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology|April 16, 2023
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis BFlorian van Bömmel, Kerstin Stein, Renate Heyne, et al.
Zeitschrift Fur Gastroenterologie|November 10, 2025
[Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults]Jonel Trebicka, Christian Steib, Alexander Zipprich, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasiansFelix Stickel, Stephan Buch, Katharina Lau, et al.
Pageof 64